Novel approaches for identification of anti-tumor drugs and new bioactive compounds
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel approaches for identification of anti-tumor drugs and new bioactive compounds
Authors
Keywords
-
Journal
JOURNAL OF ANTIBIOTICS
Volume 71, Issue 1, Pages 39-44
Publisher
Springer Nature
Online
2017-08-30
DOI
10.1038/ja.2017.97
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New anti-cancer chemicals Ertredin and its derivatives, regulate oxidative phosphorylation and glycolysis and suppress sphere formation in vitro and tumor growth in EGFRvIII-transformed cells
- (2016) Sonoko Atsumi et al. BMC CANCER
- Stability and Bioavailability of Lentztrehaloses A, B, and C as Replacements for Trehalose
- (2016) Shun-ichi Wada et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Small molecules modulating tumor–stromal cell interactions: new candidates for anti-tumor drugs
- (2016) Manabu Kawada JOURNAL OF ANTIBIOTICS
- New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice
- (2015) Shuichi Sakamoto et al. CANCER SCIENCE
- Synthesis and Determination of Absolute Configuration of Lentztrehalose A
- (2015) Ming Zhang et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Novel autophagy inducers lentztrehaloses A, B and C
- (2015) Shun-ichi Wada et al. JOURNAL OF ANTIBIOTICS
- Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
- (2015) Jessica M Foley et al. Journal of Translational Medicine
- Can Trehalose Prevent Neurodegeneration? Insights from Experimental Studies
- (2014) Enzo Emanuele CURRENT DRUG TARGETS
- Structure and biological properties of lentztrehalose: a novel trehalose analog
- (2014) Shun-ichi Wada et al. JOURNAL OF ANTIBIOTICS
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
- (2013) Hui K. Gan et al. FEBS Journal
- Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2
- (2013) Manabu Kawada et al. JOURNAL OF ANTIBIOTICS
- Synthesis of Intervenolin, an Antitumor Natural Quinolone with Unusual Substituents
- (2013) Hikaru Abe et al. ORGANIC LETTERS
- Overcoming anoikis - pathways to anchorage-independent growth in cancer
- (2011) M. C. Guadamillas et al. JOURNAL OF CELL SCIENCE
- Trehalose: Current Use and Future Applications
- (2011) Satoshi Ohtake et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Novel strategies for the treatment of small-cell lung carcinoma
- (2011) William N. William et al. Nature Reviews Clinical Oncology
- NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716
- (2010) Manabu Kawada et al. JOURNAL OF ANTIBIOTICS
- Targeting anoikis resistance in prostate cancer metastasis
- (2010) Shinichi Sakamoto et al. MOLECULAR ASPECTS OF MEDICINE
- Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions
- (2009) Manabu Kawada et al. CANCER SCIENCE
- New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells
- (2009) Manabu Kawada et al. JOURNAL OF ANTIBIOTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started